B. He

发表

Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)

Jiyan Liu, M. Qiu, F. Bi, 2011, Medical oncology.

Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics

Yong Wang, M. Cheng, Houxiang Chen, 2014, International journal of nanomedicine.

Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1

K. Zhi, M. Cheng, B. He, 2013, Molecular Cancer.

Quercetin Liposome Sensitizes Colon Carcinoma to Thermotherapy and Thermochemotherapy in Mice Models

Bo Mu, Jing Zhang, Xin Wang, 2013, Integrative cancer therapies.

Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.

B. Zha, M. Cheng, Jingbo Wu, 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma via Activation of the p53 Pathway in the Orthotopic Transplant Mouse Model

Tao Wan, B. Zha, M. Cheng, 2012, PloS one.

Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Tao Wan, B. Zha, M. Cheng, 2012, World journal of gastroenterology.

Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice

Tao Wan, B. Zha, M. Cheng, 2012, Cancer biology & therapy.

Preparation of dextran immunological magnetic nanoparticles and their application to combined targeting carrier

R. Niu, B. He, Minqin Li, 1996 .

Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo

Yong Wang, M. Cheng, Houxiang Chen, 2013, International journal of nanomedicine.

Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo

Yong Wang, M. Cheng, Houxiang Chen, 2013, Marine drugs.

Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells

Yong Wang, M. Cheng, Houxiang Chen, 2013, Drug design, development and therapy.

Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1

K. Zhi, M. Cheng, B. He, 2013, Molecular Cancer.

Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.

Tao Wan, B. Zha, M. Cheng, 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells

Yong Wang, M. Cheng, Houxiang Chen, 2013, Drug design, development and therapy.

Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics

Yong Wang, Houxiang Chen, B. He, 2014, International journal of nanomedicine.